Reiki is a pseudoscientific form of energy healing, a type of alternative medicine originating in Japan. Reiki practitioners use a technique called palm healing or hands-on healing through which, according to practitioners, a "universal energy" is transferred through the palms of the practitioner to the client, to encourage emotional or physical healing. It is based on qi ("chi"), which practitioners say is a universal life force, although there is no empirical evidence that such a life force exists.
Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy. For age-related macular degeneration it is given by injection into the eye (intravitreal).
Nature Reviews Cancer is a monthly review journal covering the field of oncology. It was established in 2001. The editor-in-chief is Anna Dart.
Endocrinology is a peer-reviewed scientific journal published by The Endocrine Society. It is the Society's oldest journal and was established in 1917. It covers research on all aspects of endocrinology, including growth factors, steroids, the thyroid, and physiology. According to the Journal Citation Reports, the journal had a 2021 impact factor of 5.051. Its current editor-in-chief is Dr. Carol A. Lange, a Professor in the Departments of Medicine and Pharmacology at the University of Minnesota Masonic Cancer Center.
Cancer Research is a biweekly peer-reviewed medical journal published by the American Association for Cancer Research. It covers research on all aspects of cancer and cancer-related biomedical sciences and was established in 1941. The editor-in-chief is Chi Van Dang.
Integrative Cancer Therapies is a peer-reviewed medical journal focusing on complementary and alternative and integrative medicine in the care for and treatment of patients with cancer. Therapies like diets and lifestyle modifications, as well as experimental vaccines and chemotherapy are the subject of this journal. It was established in 2002 and is published by SAGE Publications. The editor-in-chief is Keith I. Block.
Journal of Experimental Medicine is a monthly peer-reviewed medical journal published by Rockefeller University Press that publishes research papers and commentaries on the physiological, pathological, and molecular mechanisms that encompass the host response to disease. The journal prioritizes studies on intact organisms and has made a commitment to publishing studies on human subjects. Topics covered include immunology, inflammation, infectious disease, hematopoiesis, cancer, stem cells and vascular biology. The journal has no single editor-in-chief, but thirteen academic editors.
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical oncology. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg. JCO's Impact Factor is 45.3 as reported by Clarivate in its 2022 Journal Citation Reports.
CA: A Cancer Journal for Clinicians is a bimonthly peer-reviewed medical journal published for the American Cancer Society by Wiley-Blackwell. The journal was established in 1950 and covers aspects of cancer research on diagnosis, therapy, and prevention. The editor-in-chief is Arif Kamal.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
The Journal of the National Cancer Institute (JNCI) is a peer-reviewed medical journal covering research in oncology that was established in August 1940. It is published monthly by Oxford University Press and is edited by Patricia A. Ganz. It was merged with Cancer Treatment Reports in January 1988. JNCI used to be the official journal of the U.S. National Cancer Institute (NCI); however, in 1996, the NCI and JNCI agreed to grow apart. Over the next five years, JNCI became independent of the NCI.
Oral Oncology is a monthly peer-reviewed medical journal published by Elsevier covering research about head and neck cancer. It is the official journal of the International Association of Oral Pathologists, the European Association of Oral Medicine, and the International Academy of Oral Oncology.
Lung Cancer is a peer-reviewed medical journal published by Elsevier originally published on behalf of the International Association for the Study of Lung Cancer. As of 2015, it is published on behalf of the International Lung Cancer Consortium, the European Thoracic Oncology Platform, and the British Thoracic Oncology Group. It includes original research and review articles of relevance to lung cancer.
Rajendra Achyut Badwe, is an Indian medical doctor and surgical oncologist. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the field of medicine. He is the former Director of Tata Memorial Centre, succeeded by Sudeep Gupta
Cancer and Metastasis Reviews is a quarterly peer-reviewed medical review journal covering oncology and the development of new cancer treatments. It was established in 1982 and is published by Springer Science+Business Media. The editors-in-chief are Kenneth V. Honn and Avraham Raz. According to the Journal Citation Reports, the journal has a 2020 impact factor of 9.264.
Nature Cancer is a monthly peer-reviewed academic journal published by Nature Portfolio. It was established in 2020. The editor-in-chief is Alexia-Ileana Zaromytidou.
